Latest Articles
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
Doctor shares 6 causes of painful periods after pregnancy and how to reduce pain | Health - Hindustan Times - Hindustan Times
Doctor shares 6 causes of painful periods after pregnancy and how to reduce pain | Health - Hindustan Times Hindustan Times
Published: July 2, 2025, 8:39 a.m.
Greenock bank branch could be under threat after £2.65bn takeover is agreed - Greenock Telegraph
Greenock bank branch could be under threat after £2.65bn takeover is agreed Greenock Telegraph
Published: July 2, 2025, 7:59 a.m.
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma
Published: July 2, 2025, 7 a.m.
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer - Medical Dialogues
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer Medical Dialogues
Published: July 2, 2025, 6:31 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - Nature
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion Nature
Published: July 2, 2025, 5:48 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - nature.com
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion nature.com
Published: July 2, 2025, 5:48 a.m.
Dr Nayana Patel’s Contributions: Pioneering Research in Reproductive Medicine - Media Hindustan
Dr Nayana Patel’s Contributions: Pioneering Research in Reproductive Medicine Media Hindustan
Published: July 2, 2025, 5:42 a.m.
AstraZeneca Pharma India receives permission to import Durvalumab Solution - Indian Pharma Post
AstraZeneca Pharma India receives permission to import Durvalumab Solution Indian Pharma Post
Published: July 2, 2025, 5:11 a.m.
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution - Business Standard
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution Business Standard
Published: July 2, 2025, 4:56 a.m.
Link copied to clipboard!